Desoxyrhapontigenin, a potent anti-inflammatory phytochemical, inhibits LPS-induced inflammatory responses via suppressing NF-κB and MAPK pathways in RAW 264.7 cells

International Immunopharmacology

Volumn 18, Issue 1, 2014, Pages 182-190

  Choi, Ran Joo ^a   Chun, Jaemoo ^a   Khan, Salman ^a   Kim, Yeong Shik ^a  

^a Seoul National University   (South Korea)

Author keywords

Desoxyrhapontigenin; Inflammation; MAPK; NF B; Stilbenes

Indexed keywords

ANTIINFLAMMATORY AGENT; CARRAGEENAN; CELECOXIB; CYCLOOXYGENASE 2; DESOXYRHAPONTIGENIN; DEXAMETHASONE; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; JANUS KINASE 1; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN KINASE B; RESVERATROL; STILBENE DERIVATIVE; SYNAPTOPHYSIN; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RHEUM; RHEUM UNDULATUM; SIGNAL TRANSDUCTION;

DESOXYRHAPONTIGENIN; INFLAMMATION; MAPK; NF-ΚB; STILBENES;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; CELL LINE; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; EDEMA; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED ICR; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RHEUM; RHIZOME; STILBENES; TRANSCRIPTION FACTOR AP-1;

EID: 84889977051     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.11.022     Document Type: Article

References (48)

1. D.Y. Yang, H. Fushimi, S.Q. Cai, and K. Komatsu Molecular analysis of Rheum species used as Rhei Rhizoma based on the chloroplast matK gene sequence and its application for identification Biol Pharm Bull 27 2004 375 383 (Pubitemid 41685483)
2. M.K. Moon, D.G. Kang, J.K. Lee, J.S. Kim, and H.S. Lee Vasodilatory and anti-inflammatory effects of the aqueous extract of rhubarb via a NO-cGMP pathway Life Sci 78 2006 1550 1557 (Pubitemid 43259461)
3. J.H. Jin, T.M. Ngoc, K. Bae, Y.S. Kim, and H.P. Kim Inhibition of experimental atopic dermatitis by rhubarb (rhizomes of Rheum tanguticum) and 5-lipoxygenase inhibition of its major constituent, emodin Phytother Res 25 2011 755 759
4. J.H. Lee, J.M. Kim, and C. Kim Pharmacokinetic analysis of rhein in Rheum undulatum L J Ethnopharmacol 84 2003 5 9 (Pubitemid 36034229)
5. S.K. Ko A new stilbene diglycoside from Rheum undulatum Arch Pharm Res 23 2000 159 162
6. W. Lee, G. Yoon, Y.R. Hwang, Y.K. Kim, and S.N. Kim Anti-obesity and hypolipidemic effects of Rheum undulatum in high-fat diet-fed C57BL/6 mice through protein tyrosine phosphatase 1B inhibition BMB Rep 45 2012 141 146
7. S.Z. Choi, S.O. Lee, K.U. Jang, S.H. Chung, S.H. Park, and H.C. Kang Antidiabetic stilbene and anthraquinone derivatives from Rheum undulatum Arch Pharm Res 28 2005 1027 1030 (Pubitemid 41426847)
8. H. Matsuda, S. Tewtrakul, T. Morikawa, and M. Yoshikawa Anti-allergic activity of stilbenes from Korean rhubarb (Rheum undulatum L.): structure requirements for inhibition of antigen-induced degranulation and their effects on the release of TNF-α and IL-4 in RBL-2H3 cells Bioorg Med Chem 12 2004 4871 4876 (Pubitemid 39164395)
9. H. Matsuda, N. Tomohiro, K. Hiraba, S. Harima, S. Ko, and K. Matsuo Study on anti-Oketsu activity of rhubarb II. Anti-allergic effects of stilbene components from Rhei undulati Rhizoma (dried rhizome of Rheum undulatum cultivated in Korea) Biol Pharm Bull 24 2001 264 267 (Pubitemid 32237165)
10. H. Matsuda, T. Kageura, T. Morikawa, I. Toguchida, S. Harima, and M. Yoshikawa Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages Bioorg Med Chem Lett 10 2000 323 327 (Pubitemid 30125181)
11. H. Piotrowska, M. Kucinska, and M. Murias Biological activity of piceatannol: leaving the shadow of resveratrol Mutat Res 750 2012 60 82
12. T. Szekeres, M. Fritzer-Szekeres, P. Saiko, and W. Jager Resveratrol and resveratrol analogues - structure-activity relationship Pharm Res 27 2010 1042 1048
13. S. Pervaiz, and A.L. Holme Resveratrol: its biologic targets and functional activity Antioxid Redox Signal 11 2009 2851 2897
14. Z. Ovesna, and K. Horvathova-Kozics Structure-activity relationship of trans-resveratrol and its analogues Neoplasma 52 2005 450 455 (Pubitemid 41809401)
15. K.P. Bhat, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol Ann N Y Acad Sci 957 2002 210 229 (Pubitemid 34721666)
16. A. Buttner, and D. Thieme Side effects of anabolic androgenic steroids: pathological findings and structure-activity relationships Handb Exp Pharmacol 2010 459 484
17. P. Roth, W. Wick, and M. Weller Steroids in neurooncology: actions, indications, side-effects Curr Opin Neurol 23 2010 597 602
18. K.D. Rainsford Cardiovascular adverse reactions from NSAIDs are more than COX-2 inhibition alone Rheumatology (Oxford) 49 2010 834 836
19. I.T. Padol, and R.H. Hunt Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation Rheumatology (Oxford) 49 2010 837 843
20. F.A. Villa, and L. Gerwick Marine natural product drug discovery: leads for treatment of inflammation, cancer, infections, and neurological disorders Immunopharmacol Immunotoxicol 32 2010 228 237
21. A.P. Rogerio, A. Sa-Nunes, and L.H. Faccioli The activity of medicinal plants and secondary metabolites on eosinophilic inflammation Pharmacol Res 62 2010 298 307
22. M.H. Pan, C.S. Lai, and C.T. Ho Anti-inflammatory activity of natural dietary flavonoids Food Funct 1 2010 15 31
23. L.C. Denlinger, P.L. Fisette, K.A. Garis, G. Kwon, A. Vazquez-Torres, and A.D. Simon Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium J Biol Chem 271 1996 337 342 (Pubitemid 26026599)
24. T.M. Ngoc, P.T. Minh, T.M. Hung, P.T. Thuong, I. Lee, and B.S. Min Lipoxygenase inhibitory constituents from rhubarb Arch Pharm Res 31 2008 598 605
25. Y.H. Kim, S.H. Lee, J.Y. Lee, S.W. Choi, J.W. Park, and T.K. Kwon Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of NF-κB and c-Jun NH2-terminal kinase Eur J Pharmacol 494 2004 1 9 (Pubitemid 38759825)
26. E.M. Shin, H.Y. Zhou, G.H. Xu, S.H. Lee, I. Merfort, and Y.S. Kim Anti-inflammatory activity of hispidol A 25-methyl ether, a triterpenoid isolated from Ponciri Immaturus Fructus Eur J Pharmacol 627 2010 318 324
27. M.H. Pan, C.S. Lai, Y.J. Wang, and C.T. Ho Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice Biochem Pharmacol 72 2006 1293 1303
28. E.M. Shin, S. Kim, I. Merfort, and Y.S. Kim Glycyrol induces apoptosis in human Jurkat T cell lymphocytes via the Fas-FasL/caspase-8 pathway Planta Med 77 2011 242 247
29. Y.S. Chiou, N.J. Ma, S. Sang, C.T. Ho, Y.J. Wang, and M.H. Pan Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice J Agric Food Chem 60 2012 3441 3451
30. 2 + dependence, and differential half-site recognition J Biol Chem 266 1991 252 260 (Pubitemid 21906116)
31. R.J. Choi, E.M. Shin, H.A. Jung, J.S. Choi, and Y.S. Kim Inhibitory effects of kaurenoic acid from Aralia continentalis on LPS-induced inflammatory response in RAW264.7 macrophages Phytomedicine 18 2011 677 682
32. J.A. DiDonato, F. Mercurio, and M. Karin NF-κB and the link between inflammation and cancer Immunol Rev 246 2012 379 400
33. M. Karin The regulation of AP-1 activity by mitogen-activated protein kinases J Biol Chem 270 1995 16483 16486
34. M.D. Jacobs, and S.C. Harrison Structure of an IκB-α/NF- κB complex Cell 95 1998 749 758
35. J. Wei, and J. Feng Signaling pathways associated with inflammatory bowel disease Recent Pat Inflamm Allergy Drug Discov 4 2010 105 117
36. S. Khan, O. Shehzad, H.G. Jin, E.R. Woo, S.S. Kang, and S.W. Baek Anti-inflammatory mechanism of 15,16-epoxy-3α-hydroxylabda-8,13(16),14- trien-7-one via inhibition of LPS-induced multicellular signaling pathways J Nat Prod 75 2012 67 71
37. Y.W. Su, W.F. Chiou, S.H. Chao, M.H. Lee, C.C. Chen, and Y.C. Tsai Ligustilide prevents LPS-induced iNOS expression in RAW 264.7 macrophages by preventing ROS production and down-regulating the MAPK, NF-κB and AP-1 signaling pathways Int Immunopharmacol 11 2011 1166 1172
38. K.W. Thomas, M.M. Monick, J.M. Staber, T. Yarovinsky, A.B. Carter, and G.W. Hunninghake Respiratory syncytial virus inhibits apoptosis and induces NF-κB activity through a phosphatidylinositol 3-kinase-dependent pathway J Biol Chem 277 2002 492 501 (Pubitemid 34952084)
39. M.S. Choi, S.H. Lee, H.S. Cho, Y. Kim, Y.P. Yun, and H.Y. Jung Inhibitory effect of obovatol on nitric oxide production and activation of NF-κB/MAP kinases in lipopolysaccharide-treated RAW 264.7cells Eur J Pharmacol 556 2007 181 189 (Pubitemid 46098933)
40. H.Y. Zhou, E.M. Shin, L.Y. Guo, U.J. Youn, K. Bae, and S.S. Kang Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-κB, JNK and p38 MAPK inactivation Eur J Pharmacol 586 2008 340 349
41. H.G. Kim, D.H. Yoon, W.H. Lee, S.K. Han, B. Shrestha, and C.H. Kim Phellinus linteus inhibits inflammatory mediators by suppressing redox-based NF-κB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophage J Ethnopharmacol 114 2007 307 315 (Pubitemid 350026213)
42. I.T. Kim, S. Ryu, J.S. Shin, J.H. Choi, H.J. Park, and K.T. Lee Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages J Cell Biochem 113 2012 1936 1946
43. J.Y. Lee, J. Ye, Z. Gao, H.S. Youn, W.H. Lee, and L. Zhao Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids J Biol Chem 278 2003 37041 37051 (Pubitemid 37175218)
44. J.K. Kundu, and Y.J. Surh Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives Cancer Lett 269 2008 243 261
45. H.J. Kim, E.J. Chang, S.H. Cho, S.K. Chung, H.D. Park, and S.W. Choi Antioxidative activity of resveratrol and its derivatives isolated from seeds of Paeonia lactiflora Biosci Biotechnol Biochem 66 2002 1990 1993 (Pubitemid 39246814)
46. C.A. de la Lastra, and I. Villegas Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications Biochem Soc Trans 35 2007 1156 1160 (Pubitemid 350206449)
47. E.Y. Chung, B.H. Kim, M.K. Lee, Y.P. Yun, S.H. Lee, and K.R. Min Anti-inflammatory effect of the oligomeric stilbene α-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase Planta Med 69 2003 710 714 (Pubitemid 37215019)
48. M. Lee, S. Kim, O.K. Kwon, S.R. Oh, H.K. Lee, and K. Ahn Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma Int Immunopharmacol 9 2009 418 424